Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer

ABSTRACT: The purpose of the study is to determine the safety, tolerability and maximum tolerated dose of Urelumab in combination with Cetuximab in patients with Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Squamous Cell Carcinoma of the Head and Neck.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms,Head And Neck Neoplasms,Head And Neck Cancer

PROVIDER: 2164428 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

microRNA profiling for prediction of chemoradiation efficacy in locally advanced head and neck squamous cell carcinoma

Project description:The predictive value of microRNAs for the efficacy of chemoradiation (CRTX) in locally advanced head and neck squamous cell carcinoma (HNSCC) was evaluated. Formalin-fixed, paraffin-embedded tumor material was collected from patients with locally advanced HNSCC treated within the ARO-0401 phase III trial with radiotherapy in combination with either 5-fluorouracil/cisplatin (CDDP-CRTX) or 5-fluorouracil/mitomycin C (MMC-CRTX).

2017-03-30 | E-MTAB-5198 | biostudies-arrayexpress

Gene expression profiles of head and neck squamous cell carcinoma

Project description:Sage performed on microdissection of Head and Neck tumor, and Head and Neck normal tissue comparative analysis of gene expression profiles of head and neck squamous cell carcinoma and Head and Neck normal tissue

2008-09-30 | E-GEOD-11986 | biostudies-arrayexpress

Investigation of head and neck squamous carcinoma (HNSCC) spatial transcriptome evolution

Project description:We collected matched pairs of primary tumor (invasive front and intra-tumor region), metastatic region and adjacent normal tissue from head and neck squamous cell carcinoma patients at the Taipei Veterans General Hospital (TVGH) for RNA sequencing analysis.

2022-08-29 | GSE178537 | GEO

Suqamous Cell Carcinoma of Head and Neck

Project description:Gene Expression Analysis of Squamous Cell Carcinoma of Head and Neck Keywords: parallel sample

2005-12-14 | GSE2326 | GEO

Molecular subtypes of head and neck cancer – Prognostic impact and correlations with morphological characteristics

Project description:Aim Treatment options for patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC) are limited. Therefore, prognostic and predictive biomarkers for the application of personalized therapies are urgently needed.

2023-06-01 | GSE212070 | GEO

Phase I trial of intravenous VCN-01 oncolytic adenovirus and durvalumab in patients with head and neck metastatic squamous cell carcinoma refractory to immunotherapy

Project description:VCN-01 is a hyaluronidase-expressing oncolytic adenovirus that increases immune checkpoint antibody tumor uptake in mice. VCN-01 was evaluated with durvalumab in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) patients refractory to anti-PD-(L)1

2026-06-03 | GSE333537 | GEO

Analysis of microRNAs expression in four head and neck cancer cell lines

Project description:MicroRNA expression in two pair of head and neck squamous cell carcinoma cell lines were analyzed. 4A/4B and 37A/37B cells were from two different head and neck squamous cell carcinoma patients. A cells were from patients' primary focus. B cells were from patients' lymph node metastasis. B cells have higher migratory and invasive abilities and CCR7 expression levels than A cell.

2021-05-01 | GSE115000 | GEO

Transcription profiling of human squamous cell carcinoma of head and neck

Project description:Gene Expression Analysis of Squamous Cell Carcinoma of Head and Neck

2008-06-12 | E-GEOD-2326 | biostudies-arrayexpress

Redox proteomics analysis of head and neck cancer cell model of radiation resistance

Project description:Quantitative redox proteomics analysis was performed using the SCC-61/rSCC-61 matched model system of radiation resistance in human head and neck squamous cell carcinoma.

2023-03-10 | PXD029053 | Pride

A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

Project description:To determine the differential expression of KRAS-variant HNSCC (head and neck squamous cell carcinoma) cell lines.

2014-10-02 | GSE36110 | GEO